Anal cancer is fortunately very rare, as it is a very difficult cancer to screen for, and the treatment is brutal. Many of those who experience it will not talk about it, due to the stigmas surrounding this cancer. Years ago breast and prostate cancer were unmentionable; it took high-profile patients such as former First Lady Betty Ford to break this taboo. Farrah Fawcett’s well-known anal cancer may have begun this process, but secrecy and shame are still part of the anal cancer experience for many. If you have been diagnosed with anal cancer, you must expect some of your friends and relatives to be squeamish about it, and you will have to work out how to deal with this reaction. If you can be open about it, and even clarify for your friends and family that the underlying virus can be transmitted in a number of ways, and most of us have been infected at one time or another, you will help to remove the stigma.
The National Cancer Institute estimates that there will be 7060 new cases in the U.S. in 2012, most with a Squamous Cell Anal Carcinoma (SCAC), and 880 deaths from anal cancer this year. Incidence of anal cancer is rising, and the proportion of women among those diagnosed is increasing - more women are reported with this cancer than men. In the past three decades reported cases have gone up some 60% for males and almost 80% for women. HPV vaccination could prevent most of these cancers, but vaccination rates in the US are very low. Until a significant part of the population has been vaccinated, increasing numbers for this cancer diagnosis can be expected.
Screening and Diagnosis
Anal cancer and hemorrhoids often have the same symptoms. Even experienced doctors have mistakenly diagnosed hemorrhoids when the problem was anal cancer. Some doctors never examine the anal area, even though a “digital rectal exam” (DRE) requires no special equipment and not much training. Many if not most patients either do not know about this kind of examination or are reluctant to ask for it. The American Cancer Society itself dropped the recommendation for an annual DRE after 1997, in favor of examinations such as a colonoscopy or sigmoidoscopy that are only done every 5 or every 10 years —arguably increasing the probability of missed anal cancer signs. Chronological History of ACS Recommendations for the Early Detection of Cancer in Asymptomatic People
Symptoms such as rectal bleeding or pain, sensitivity in the groin, changes in bowel habits, and excessive gas or bloating, may be ignored or attributed to hemorrhoids. The result, recounted by numerous anal cancer patients and confirmed in medical literature, is delayed diagnosis.
If you are reading this and have not been diagnosed with an anal cancer, but have been told over time you have hemorrhoids – consider consulting a colorectal doctor soon!! This is especially true if you have any of the symptoms mentioned above. A DRE and if possible an anoscopy, or proctoscopy, a simple exam with a small instrument that enables a magnified look at the area under a light, determine if there is any cause for concern. For more information on this procedure, see the National Institutes of Health, or the Harvard Medical School websites. An online search will also bring up videos of the procedure in action; you may not want to view them before you have one! Please note that an anoscopy is very different from a colonoscopy or flexible sigmoidoscopy, neither of which can adequately exam the anal canal for signs of anal dysplasia or tumors. The risk factors for anal canal are not the same as those for colon cancer, and there is no evidence that anal cancer patients are more likely to have colon cancer. Talk to your oncologist and your colorectal surgeon or gastroenterologist about these screening or followup procedures.
An improvement in followup of an abnormal Pap smear has been developed and approved for use in Canada and the UK but prospects for approval by the US FDA in the US are uncertain. (Research is underway in the US to review anal cancer screening for women during regular visits to the gynecologist.) This website author wonders if the same kind of biophotonic (light) technology might be applied to anal cancer scans; in the meantime, a periodic DRE and anoscopy is essential in the presence of persistent hemorrhoids or rectal bleeding. If you hear "don't worry about it," regarding your hemorrhoids, that may be the time to head for a colorectal surgeon. Listen to your body and your instincts!
The long-range goal of many cancer researchers now is improving detection methods so that cancers are detected far earlier than they are now. in the meantime, improvement of treatment - increasing effectiveness and reducing toxicity - is a key part of the story. While research on anal cancer is limited to some extent by its rarity, there are some new avenues being explored.
Following any initial diagnosis for anal cancer, your medical team will order scans to determine if the cancer has spread to any distant sites; the same tests may be part of your follow-up program. You may have encountered some of these scans as diagnostic tools for other medical problems; I did not have a clear understanding of the PET scan until I had to have one! Find a good explanation here.
Before the 1970s, most anal cancer was generally treated by a rather brutal operation that removed the anus and lower rectum, leaving the patient with a permanent colostomy (feces bag), and survival rates after 5 years as low as 40%. In 1974 Dr. Norman D. Nigro, of Wayne State University School of Medicine, published a review of patients who had been treated with combined radiation and chemotherapy – first to reduce the tumor prior to surgery, but later only with the combined regime, when it was realized this was as successful as the surgery. This combined regime has been studied and tested over the years, and improved with better-targeted radiation; but it remains the standard treatment for anal cancer, known now as the Nigro Protocol. (Dr. Nigro retired to Arizona, where he passed away in 2009.)
When caught early, this treatment is highly effective, with an 80% five-year cancer-free survival rate. Survival rates when the cancer is not diagnosed until a later stage drop to to 60%. (The National Cancer Institute, the American Cancer Society, and the Cancer Guide site all offer information for patients about staging.) These are still better survival rates than many of the other cancers related to HPV, such as cervical cancer (see below).
See the National Comprehensive Cancer Network site Clinical Practices Guidelines for anal carcinoma. Registration for the Clinical Practices material is required - you do not have to be a physician to register. The guidelines are updated periodically; the guidelines for 2013 are now posted.
Many cancer treatment sites now provide advice or access to "complementary treatment," such as meditation or nutrition counseling, help with sleep disorders, and the like. This may be referred to as "integrative medicine;" these are aids to the standard treatment, to ease difficulties or improve emotional health. There is no known alternative treatment for anal cancer that eliminates the chemoradiation of the Nigro Protocol. If you have been diagnosed with anal cancer, pursue acupunture, meditation, a better diet, or anything else that helps you with the treatment; but please do not try to substitute these for the treatment that you need to beat this cancer! See the Cancer Guide site for a discussion of this. You may also want to consider a clinical trial - a discussion on how to find and enter such a trial, with your physician's help, is here in the Cure magazine. Brown University, for example, is conducting trials of specific immunotherapy for HPV-related anal cancer (virtually all anal cancer).
HPV and Cancer
The Centers for Disease Control and Prevention (CDC) reports that approximately 85% of anal cancers are considered to arise from infection with the Human Papillomavirus, often abbreviated as HPV. (The Papillomavirus family is named from the Latin word papilla for bud, after the budding habit of these viruses.) Papillomaviruses have been identified in humans, rabbits, cows, birds and reptiles; some researchers have posited that the first land vertebrates, ancestors of today’s reptiles, birds and mammals, were already hosting this virus three hundred million years ago. As human beings evolved the Human Papillomavirus evolved with them; over 200 strains of this family have been identified. Various studies done after the virus was isolated in the 20th century have shown that the majority of us, perhaps 80% or more, are either infected or carry antibodies, indicating a past infection. In most cases the virus co-existed with the human in a kind of balance, not growing in ways that threatened the life of the host. For a small, but growing, number the balance breaks down and cancer develops. This may be the result of stress, smoking, or other health problems that suppress the immune system. While medical science is aware of risk factors, exactly who will develop a cancer or other health problem* as the result of HPV infection is not known.
HPV is associated with anal, cervical, vaginal and vulvar, and penile cancers, and more recently with head and neck cancers. Researchers are also finding evidence of HPV infection in breast cancers, and prostate cancers.
For more information on this virus family:
A Planet of Viruses, by Carl Zimmer, and What your Doctor May Not Tell You about HPV and Abnormal Pap Smears, by Joel Palefsky, M.D., with Jody Handley.
The Centers for Disease Control and Prevention website covers HPV in detail at What is HPV.
The HPV and Anal Cancer Foundation (see Key Websites) attends and posts a report each year on an international HPV conference, held in 2012 in Puerto Rico. The link for the 2012 report is here.
HPV is transmitted by skin contact. This is frequently by sexual activity, and HPV infection is described as a sexually transmitted disease, or STD. But sex need not be involved in this transmission. Newly diagnosed patients may be embarrassed to learn that anal cancer is characterized as an STD; it is important to understand that the infection is extremely common, and can occur without anal sex, or any sexual contact at all.
Anal cancer affects more women than men, but the highest risk for this disease is among gay men, men having sex with men (MSM in the literature). “Main-stream” reporting on this cancer often leaves the impression that anal cancer results only from anal sex. Such inaccurate reporting overlooks the other risk factors for anal cancer, such as smoking, and perpetuates a stereotype that contributes to the shame that many such patients sense about this diagnosis.
Anal cancer has been associated with HPV strains 16 and 18. These two HPV strains are also associated with cervical, vaginal and vulvar cancers (and HPV strains are also causative agents in penile, mouth and throat cancers.)
A vaccine now exists that offers protection against HPV 16 and 18, and two other strains that cause genital warts; and it is approved by the FDA for both young women and young men. For more information the New York Times has a very informative article, A Vaccine May Shield Boys Too available online, see also the online Oncology Journal, Cancer Network here. And a new study shows the vaccine's protective action against anal cancer. In October 2011 the Centers for Disease Control's Advisory Committee on Immunization Practices recommended the vaccine for boys and young men (Panel Endorses HPV Vaccine for Boys of 11), and spoke to concerns that the vaccine had adverse effects . Another study indicates that young women who receive this vaccination are not more likely to engage in risky sexual behavior - e.g., be promiscuous. A good discussion of this issue appeared in the Boston Globe M.D.Mama column.
See also the National Cancer Institute report on the reduction of precancerous lesions. (This report states that anal cancer is especially prevalent in men having sex with men - which refers to the overall incidence within this sub-population of the whole US population. More women than men have this cancer.) Charlotte Haug, M.D., discusses the risks and benefits of this vaccine in the Journal of the American Medical Assciation here. For a view from the British Medical Journal, see this.
New research also seems to indicate that HPV vaccination can help prevent new infections, even among those who have had severe HPV-related disease such as cancer. (Canada has raised their upper age limit to 45, while the US CDC keeps the limit at 26 - why?) For more details on this research and the implications for those of us who've had an HPV-related cancer, see this Science Daily story, and the summary from the British Medical Journal where the research was published. ABC News had a good report as well. While this news is important, recent studies conducted in Sweden indicate that the protective effect of the vaccine is greater the earlier that the shots are given.
Patients with HPV infections or HPV-related diseases can find help here in the HPV Support Network.
On the HPV test:
Risk factors and incidence of anal cancer:
For additional detailed information on anal cancer, see the Key Websites Page.
*Recent research suggests that an HPV infection in women may raise the risk of heart attack or stroke.